GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » American Cryostem Corp (OTCPK:CRYO) » Definitions » Piotroski F-Score

American Cryostem (American Cryostem) Piotroski F-Score

: 0 (As of Today) 中文
View and export this data going back to 2010. Start your Free Trial

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

American Cryostem has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for American Cryostem's Piotroski F-Score or its related term are showing as below:


American Cryostem Piotroski F-Score Historical Data

The historical data trend for American Cryostem's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Cryostem Annual Data
Trend Sep12 Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21
Piotroski F-Score
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.00 3.00 3.00 5.00 1.00

American Cryostem Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Piotroski F-Score Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.00 1.00 3.00 4.00 4.00

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun22) TTM:Last Year (Jun21) TTM:
Net Income was -2.062 + -0.381 + -0.964 + -0.402 = $-3.81 Mil.
Cash Flow from Operations was 0.011 + -0.532 + -0.044 + -0.123 = $-0.69 Mil.
Revenue was -0.363 + 0.061 + 0.032 + 0.043 = $-0.23 Mil.
Gross Profit was -0.368 + 0.042 + 0.029 + 0.038 = $-0.26 Mil.
Average Total Assets from the begining of this year (Jun21)
to the end of this year (Jun22) was
(1.778 + 1.056 + 1.142 + 1.132 + 1.058) / 5 = $1.2332 Mil.
Total Assets at the begining of this year (Jun21) was $1.78 Mil.
Long-Term Debt & Capital Lease Obligation was $0.15 Mil.
Total Current Assets was $0.12 Mil.
Total Current Liabilities was $1.55 Mil.
Net Income was -0.53 + -0.046 + -0.305 + -0.466 = $-1.35 Mil.

Revenue was 0.125 + 0.127 + 0.127 + 0.13 = $0.51 Mil.
Gross Profit was 0.102 + 0.123 + 0.122 + 0.129 = $0.48 Mil.
Average Total Assets from the begining of last year (Jun20)
to the end of last year (Jun21) was
(1.365 + 1.477 + 1.594 + 1.8 + 1.778) / 5 = $1.6028 Mil.
Total Assets at the begining of last year (Jun20) was $1.37 Mil.
Long-Term Debt & Capital Lease Obligation was $0.28 Mil.
Total Current Assets was $0.91 Mil.
Total Current Liabilities was $1.19 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

American Cryostem's current Net Income (TTM) was -3.81. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

American Cryostem's current Cash Flow from Operations (TTM) was -0.69. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Jun21)
=-3.809/1.778
=-2.14229471

ROA (Last Year)=Net Income/Total Assets (Jun20)
=-1.347/1.365
=-0.98681319

American Cryostem's return on assets of this year was -2.14229471. American Cryostem's return on assets of last year was -0.98681319. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

American Cryostem's current Net Income (TTM) was -3.81. American Cryostem's current Cash Flow from Operations (TTM) was -0.69. ==> -0.69 > -3.81 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Jun22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun21 to Jun22
=0.151/1.2332
=0.12244567

Gearing (Last Year: Jun21)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun20 to Jun21
=0.278/1.6028
=0.17344647

American Cryostem's gearing of this year was 0.12244567. American Cryostem's gearing of last year was 0.17344647. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Jun22)=Total Current Assets/Total Current Liabilities
=0.115/1.545
=0.07443366

Current Ratio (Last Year: Jun21)=Total Current Assets/Total Current Liabilities
=0.908/1.194
=0.76046901

American Cryostem's current ratio of this year was 0.07443366. American Cryostem's current ratio of last year was 0.76046901. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

American Cryostem's number of shares in issue this year was 43.995. American Cryostem's number of shares in issue last year was 60.496. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=-0.259/-0.227
=1.14096916

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=0.476/0.509
=0.93516699

American Cryostem's gross margin of this year was 1.14096916. American Cryostem's gross margin of last year was 0.93516699. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Jun21)
=-0.227/1.778
=-0.12767154

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Jun20)
=0.509/1.365
=0.37289377

American Cryostem's asset turnover of this year was -0.12767154. American Cryostem's asset turnover of last year was 0.37289377. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+1+0+1+1+0
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

American Cryostem has an F-score of 4 indicating the company's financial situation is typical for a stable company.

American Cryostem  (OTCPK:CRYO) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


American Cryostem Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of American Cryostem's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


American Cryostem (American Cryostem) Business Description

Traded in Other Exchanges
N/A
Address
1 Meridian Road, Suite 5, Eatontown, NJ, USA, 07724
American Cryostem Corp is a biotechnology company which standardizes adipose tissue-derived technologies (Adult Stem Cells) for the fields of Regenerative and Personalized Medicine. The company acts as an innovator of adipose tissue and stem cell platform technologies. It provides the clinical grade, adipose tissue and adult stem cell collection, processing, and cryo-preservation technology, providing first-in-class cellular therapy products and services for patients, physicians and researchers based on the transformative science of Regenerative and Personalized Medicine.
Executives
John S Arnone director, officer: Chairman 111 GREAT NECK RD, GREAT NECK NY 11021
Anthony Francis Dudzinski director, officer: COO 188 EAST BERGEN PLACE, SUITE 204, RED BANK NJ 07701
Acs Global, Inc. 10 percent owner 188 E. BERGEN PLACE, SUITE 204, RED BANK NJ 07701
Christopher Joseph Neill 10 percent owner 188 EAST BERGEN PLACE, SUITE 204, RED BANK NJ 07701
Hector Medina director, 10 percent owner, officer: President and Director 1206 STAGECOACH TRAIL LOOP, CHULA VISTA CA 91915

American Cryostem (American Cryostem) Headlines